Published in Plast Reconstr Surg on October 01, 2011
Hypoxia-inducible factor as an angiogenic master switch. Front Pediatr (2015) 0.88
Tumor angiogenesis: therapeutic implications. N Engl J Med (1971) 35.36
Isolation of putative progenitor endothelial cells for angiogenesis. Science (1997) 30.27
Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci U S A (1995) 24.77
Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell (2005) 18.20
Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol (1996) 15.20
Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell (1994) 13.76
Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg (1982) 12.85
Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med (2004) 11.71
Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature (1998) 11.61
Angiogenesis: an organizing principle for drug discovery? Nat Rev Drug Discov (2007) 11.46
Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res (1999) 11.32
Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med (2001) 10.36
Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell (1998) 10.32
Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med (1999) 10.16
Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat Med (2001) 9.53
Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell (2002) 9.36
Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood (2000) 9.24
VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J (1999) 6.62
Therapy-induced acute recruitment of circulating endothelial progenitor cells to tumors. Science (2006) 4.79
Adipose tissue mass can be regulated through the vasculature. Proc Natl Acad Sci U S A (2002) 4.77
Defective angiogenesis in mice lacking endoglin. Science (1999) 4.40
Anti-angiogenesis: new concept for therapy of solid tumors. Ann Surg (1972) 4.37
Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat Med (2002) 4.25
Suppressed NFAT-dependent VEGFR1 expression and constitutive VEGFR2 signaling in infantile hemangioma. Nat Med (2008) 3.98
Adult hematopoietic stem cells provide functional hemangioblast activity during retinal neovascularization. Nat Med (2002) 3.81
Genetic heterogeneity of the vasculogenic phenotype parallels angiogenesis; Implications for cellular surrogate marker analysis of antiangiogenesis. Cancer Cell (2005) 3.74
Arteriovenous malformations of the head and neck: natural history and management. Plast Reconstr Surg (1998) 3.42
Vascular endothelial growth factor and angiopoietin-1 stimulate postnatal hematopoiesis by recruitment of vasculogenic and hematopoietic stem cells. J Exp Med (2001) 3.25
Contribution of bone marrow-derived endothelial cells to human tumor vasculature. Nat Med (2005) 3.19
Vascular endothelial growth factor mediates angiogenic activity during the proliferative phase of wound healing. Am J Pathol (1998) 3.05
Arteriovenous malformations in mice lacking activin receptor-like kinase-1. Nat Genet (2000) 2.65
Capillary malformation-arteriovenous malformation, a new clinical and genetic disorder caused by RASA1 mutations. Am J Hum Genet (2003) 2.56
VEGF165 mediates formation of complexes containing VEGFR-2 and neuropilin-1 that enhance VEGF165-receptor binding. J Cell Biochem (2002) 2.53
Bone marrow-derived endothelial progenitor cells participate in cerebral neovascularization after focal cerebral ischemia in the adult mouse. Circ Res (2002) 2.45
Adult vasculogenesis occurs through in situ recruitment, proliferation, and tubulization of circulating bone marrow-derived cells. Blood (2004) 2.21
Patterns of expression of vascular endothelial growth factor (VEGF) and VEGF receptors in mice suggest a role in hormonally regulated angiogenesis. J Clin Invest (1993) 2.07
Regulation of vascular endothelial growth factor (VEGF) gene transcription by estrogen receptors alpha and beta. Proc Natl Acad Sci U S A (2000) 1.72
The vascular endothelial growth factor (VEGF) receptor Flt-1 (VEGFR-1) modulates Flk-1 (VEGFR-2) signaling during blood vessel formation. Am J Pathol (2004) 1.61
Extracranial arteriovenous malformations: natural progression and recurrence after treatment. Plast Reconstr Surg (2010) 1.61
Endothelial progenitor cells in infantile hemangioma. Blood (2003) 1.50
Endothelial progenitor cells from infantile hemangioma and umbilical cord blood display unique cellular responses to endostatin. Blood (2006) 1.40
Opposing actions of intact and N-terminal fragments of the human prolactin/growth hormone family members on angiogenesis: an efficient mechanism for the regulation of angiogenesis. Proc Natl Acad Sci U S A (1999) 1.35
Endothelial-directed hepatic regeneration after partial hepatectomy. Ann Surg (2003) 1.34
Hypoxia-induced mediators of stem/progenitor cell trafficking are increased in children with hemangioma. Arterioscler Thromb Vasc Biol (2007) 1.33
Inhibition of vascular endothelial growth factor (VEGF)-induced endothelial cell proliferation by a peptide corresponding to the exon 7-encoded domain of VEGF165. J Biol Chem (1997) 1.33
Is tissue mass regulated by vascular endothelial cells? Prostate as the first evidence. Endocrinology (1998) 1.28
Continuous infusion of endostatin inhibits differentiation, mobilization, and clonogenic potential of endothelial cell progenitors. Clin Cancer Res (2003) 1.23
Neuropilin-1 regulates vascular endothelial growth factor-mediated endothelial permeability. Circ Res (2005) 1.21
Arteriovenous fistulas: a review and ten-year experience at the Mayo Clinic. Mayo Clin Proc (1970) 1.11
High flow drives vascular endothelial cell proliferation during flow-induced arterial remodeling associated with the expression of vascular endothelial growth factor. Exp Mol Pathol (2003) 1.10
Regulation of vascular endothelial growth factor expression by estrogens and progestins. Environ Health Perspect (2000) 1.07
VEGF increases engraftment of bone marrow-derived endothelial progenitor cells (EPCs) into vasculature of newborn murine recipients. Proc Natl Acad Sci U S A (2002) 1.06
Selective recruitment of endothelial progenitor cells to ischemic tissues with increased neovascularization. Plast Reconstr Surg (2004) 0.98
Increased circulating AC133+ CD34+ endothelial progenitor cells in children with hemangioma. Lymphat Res Biol (2003) 0.95
Neuron restrictive silencer factor NRSF/REST is a transcriptional repressor of neuropilin-1 and diminishes the ability of semaphorin 3A to inhibit keratinocyte migration. J Biol Chem (2005) 0.93
Angiogenic activity of anterior pituitary tissue and growth hormone on the chick embryo chorio-allantoic membrane: a novel action of GH. Life Sci (1995) 0.88
Hypoxia-inducible factor and vascular endothelial growth factor are expressed more frequently in embolized than in nonembolized cerebral arteriovenous malformations. Neurosurgery (2004) 0.84
Endovascular treatment of aneurysms: healing mechanisms in a Swine model are associated with increased expression of matrix metalloproteinases, vascular cell adhesion molecule-1, and vascular endothelial growth factor, and decreased expression of tissue inhibitors of matrix metalloproteinases. AJNR Am J Neuroradiol (2007) 0.81
Heart valve development: endothelial cell signaling and differentiation. Circ Res (2004) 4.41
Suppressed NFAT-dependent VEGFR1 expression and constitutive VEGFR2 signaling in infantile hemangioma. Nat Med (2008) 3.98
Engineering robust and functional vascular networks in vivo with human adult and cord blood-derived progenitor cells. Circ Res (2008) 3.50
In vivo vasculogenic potential of human blood-derived endothelial progenitor cells. Blood (2007) 3.24
Somatic mosaic activating mutations in PIK3CA cause CLOVES syndrome. Am J Hum Genet (2012) 3.13
Venous malformations of skeletal muscle. Plast Reconstr Surg (2002) 2.79
Capillary malformation-arteriovenous malformation, a new clinical and genetic disorder caused by RASA1 mutations. Am J Hum Genet (2003) 2.56
Calcification of multipotent prostate tumor endothelium. Cancer Cell (2008) 2.49
Effect of an imaging protocol on clinical outcomes among pediatric patients with appendicitis. Pediatrics (2002) 2.47
Current management of hemangiomas and vascular malformations. Clin Plast Surg (2005) 2.27
Intramuscular capillary-type hemangioma: radiologic-pathologic correlation. Pediatr Radiol (2014) 2.16
Corticosteroid suppression of VEGF-A in infantile hemangioma-derived stem cells. N Engl J Med (2010) 2.16
Multipotential stem cells recapitulate human infantile hemangioma in immunodeficient mice. J Clin Invest (2008) 2.10
RASA1: variable phenotype with capillary and arteriovenous malformations. Curr Opin Genet Dev (2005) 2.10
Active adaptation of the tethered mitral valve: insights into a compensatory mechanism for functional mitral regurgitation. Circulation (2009) 2.08
Lipocalin 2 promotes breast cancer progression. Proc Natl Acad Sci U S A (2009) 2.08
A clinical decision rule to identify children at low risk for appendicitis. Pediatrics (2005) 2.06
Psychological impact of breast asymmetry on adolescents: a prospective cohort study. Plast Reconstr Surg (2014) 2.03
Validity and reliability of craniofacial anthropometric measurement of 3D digital photogrammetric images. Cleft Palate Craniofac J (2008) 2.02
Parkes Weber syndrome, vein of Galen aneurysmal malformation, and other fast-flow vascular anomalies are caused by RASA1 mutations. Hum Mutat (2008) 2.00
Somatic mutations in angiopoietin receptor gene TEK cause solitary and multiple sporadic venous malformations. Nat Genet (2008) 1.95
Mutations in TCF12, encoding a basic helix-loop-helix partner of TWIST1, are a frequent cause of coronal craniosynostosis. Nat Genet (2013) 1.82
Variation in IRF6 contributes to nonsyndromic cleft lip and palate. Am J Med Genet A (2005) 1.82
Human pulmonary valve progenitor cells exhibit endothelial/mesenchymal plasticity in response to vascular endothelial growth factor-A and transforming growth factor-beta2. Circ Res (2006) 1.80
TFAP2A mutations result in branchio-oculo-facial syndrome. Am J Hum Genet (2008) 1.79
Fatty acid binding protein 4 is a target of VEGF and a regulator of cell proliferation in endothelial cells. FASEB J (2009) 1.79
Infantile hemangiomas: current knowledge, future directions. Proceedings of a research workshop on infantile hemangiomas, April 7-9, 2005, Bethesda, Maryland, USA. Pediatr Dermatol (2005) 1.77
Kaposiform hemangioendothelioma without Kasabach-Merritt phenomenon. J Am Acad Dermatol (2005) 1.77
The effect of hospital volume of pediatric appendectomies on the misdiagnosis of appendicitis in children. Pediatrics (2004) 1.76
Epoxyeicosanoids stimulate multiorgan metastasis and tumor dormancy escape in mice. J Clin Invest (2011) 1.74
Rapamycin suppresses self-renewal and vasculogenic potential of stem cells isolated from infantile hemangioma. J Invest Dermatol (2011) 1.74
Effects of race, insurance status, and hospital volume on perforated appendicitis in children. Pediatrics (2005) 1.73
Glomuvenous malformation (glomangioma) and venous malformation: distinct clinicopathologic and genetic entities. Arch Dermatol (2004) 1.73
Increased expression of urinary matrix metalloproteinases parallels the extent and activity of vascular anomalies. Pediatrics (2005) 1.72
Targeting angiogenesis with a conjugate of HPMA copolymer and TNP-470. Nat Med (2004) 1.70
Tumor endothelial cells express epidermal growth factor receptor (EGFR) but not ErbB3 and are responsive to EGF and to EGFR kinase inhibitors. Cancer Res (2006) 1.67
Mutations in a novel factor, glomulin, are responsible for glomuvenous malformations ("glomangiomas"). Am J Hum Genet (2002) 1.66
Resection of amblyogenic periocular hemangiomas: indications and outcomes. Plast Reconstr Surg (2010) 1.65
The spectrum of vascular anomalies in patients with PTEN mutations: implications for diagnosis and management. J Med Genet (2007) 1.64
Kaposiform hemangioendothelioma: atypical features and risks of Kasabach-Merritt phenomenon in 107 referrals. J Pediatr (2012) 1.63
Extracranial arteriovenous malformations: natural progression and recurrence after treatment. Plast Reconstr Surg (2010) 1.61
Blue rubber bleb nevus syndrome: surgical eradication of gastrointestinal bleeding. Ann Surg (2005) 1.59
Tissue-engineered microvessels on three-dimensional biodegradable scaffolds using human endothelial progenitor cells. Am J Physiol Heart Circ Physiol (2004) 1.59
Neonatal thoracoscopic repair of congenital diaphragmatic hernia: selection criteria for successful outcome. J Pediatr Surg (2005) 1.57
Involvement of the basilar coronal ring in unilateral coronal synostosis. Plast Reconstr Surg (2005) 1.52
Endothelial progenitor cells in infantile hemangioma. Blood (2003) 1.50
NFATc1 mediates vascular endothelial growth factor-induced proliferation of human pulmonary valve endothelial cells. J Biol Chem (2002) 1.46
Maternal vitamin K deficient embryopathy: association with hyperemesis gravidarum and Crohn disease. Am J Med Genet A (2013) 1.46
Lower-extremity lymphedema and elevated body-mass index. N Engl J Med (2012) 1.45
Robin sequence: a retrospective review of 115 patients. Int J Pediatr Otorhinolaryngol (2006) 1.45
Current surgical management of bilateral cleft lip in North America. Plast Reconstr Surg (2012) 1.44
Gorham-Stout disease and generalized lymphatic anomaly--clinical, radiologic, and histologic differentiation. Skeletal Radiol (2013) 1.44
Hepatic hemangiomas: subtype classification and development of a clinical practice algorithm and registry. J Pediatr Surg (2007) 1.43
Speech outcomes following pharyngeal flap in patients with velocardiofacial syndrome. Plast Reconstr Surg (2011) 1.42
Endothelial progenitor cells from infantile hemangioma and umbilical cord blood display unique cellular responses to endostatin. Blood (2006) 1.40
The Changing Nasolabial Dimensions following Repair of Unilateral Cleft Lip: An Anthropometric Study in Late Childhood. Plast Reconstr Surg (2016) 1.40
Variation in WNT genes is associated with non-syndromic cleft lip with or without cleft palate. Hum Mol Genet (2008) 1.39
Homocystinuria: an unrecognized cause of microvascular failure. Plast Reconstr Surg (2007) 1.39
Newborn and toddler intestinal obstruction owing to congenital mesenteric defects. J Pediatr Surg (2008) 1.38
Primary lymphedema: clinical features and management in 138 pediatric patients. Plast Reconstr Surg (2011) 1.38
Infantile hepatic hemangiomas: clinical and imaging findings and their correlation with therapy. AJR Am J Roentgenol (2004) 1.36
Differential expression of CD146 in tissues and endothelial cells derived from infantile haemangioma and normal human skin. J Pathol (2003) 1.35
CRISPLD2: a novel NSCLP candidate gene. Hum Mol Genet (2007) 1.32
Rapidly involuting congenital hemangioma: clinical and histopathologic features. Pediatr Dev Pathol (2004) 1.32
Mitral valve endothelial cells with osteogenic differentiation potential. Arterioscler Thromb Vasc Biol (2010) 1.31
Type I collagen, fibrin and PuraMatrix matrices provide permissive environments for human endothelial and mesenchymal progenitor cells to form neovascular networks. J Tissue Eng Regen Med (2011) 1.29
Evidence by molecular profiling for a placental origin of infantile hemangioma. Proc Natl Acad Sci U S A (2005) 1.28
Mesenchymal stem cells and adipogenesis in hemangioma involution. Stem Cells (2006) 1.25
IGF-2 and FLT-1/VEGF-R1 mRNA levels reveal distinctions and similarities between congenital and common infantile hemangioma. Pediatr Res (2008) 1.25
Management of parotid hemangioma in 100 children. Plast Reconstr Surg (2004) 1.24
Verrucous hemangioma revisited. Pediatr Dermatol (2006) 1.22
The presentation and management of nasal dermoid: a 30-year experience. Arch Otolaryngol Head Neck Surg (2003) 1.22
Esophageal atresia, duodenal atresia, and unilateral lung agenesis: a case report. J Pediatr Surg (2004) 1.22
The origin of EFNB1 mutations in craniofrontonasal syndrome: frequent somatic mosaicism and explanation of the paucity of carrier males. Am J Hum Genet (2006) 1.22
Vascular lesions of bone in children, adolescents, and young adults. A clinicopathologic reappraisal and application of the ISSVA classification. Virchows Arch (2008) 1.22
AC133-2, a novel isoform of human AC133 stem cell antigen. J Biol Chem (2002) 1.21
Childhood asymmetric labium majus enlargement: mimicking a neoplasm. Am J Surg Pathol (2005) 1.19